These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975 [TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018 [TBL] [Abstract][Full Text] [Related]
13. Effects of antibodies obtained from patients with dilated cardiomyopathy on the function of isolated rat hearts. Staudt Y; Trimpert C; Birkenmeier K; Krieg T; Bemmann T; Beug D; Felix SB; Staudt A Eur J Clin Invest; 2006 Feb; 36(2):85-90. PubMed ID: 16436089 [TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes. Saygili E; Noor-Ebad F; Schröder JW; Mischke K; Saygili E; Rackauskas G; Marx N; Kelm M; Rana OR Biochem Biophys Res Commun; 2015 Sep; 465(1):119-24. PubMed ID: 26248134 [TBL] [Abstract][Full Text] [Related]
16. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Felix SB; Staudt A Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418 [TBL] [Abstract][Full Text] [Related]
17. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508 [TBL] [Abstract][Full Text] [Related]
18. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip. Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013 [TBL] [Abstract][Full Text] [Related]
20. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Dandel M; Wallukat G; Potapov E; Hetzer R Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]